GlassScriptPhysician profile
Cheryl L Conrad
NPI 1245267095
$2,600.14
in general payments reported to CMS, 2019-2025
18 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $57.25 · 2021: $238 · 2022: $416 · 2023: $652 · 2024: $732 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,670.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $870.40 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Abbott Laboratories | $259.05 | 2022-2024 | Proclaim, Freestyle Libre 3 |
| Collegium Pharmaceutical, INC. | $231.88 | 2021-2023 | Xtampza |
| Scilex Pharmaceuticals INC. | $159.33 | 2019-2024 | |
| Abbvie INC. | $130.36 | 2021-2023 | |
| Nevro Corp. | $116.23 | 2023-2024 | Senza |
| Boston Scientific Corporation | $115.29 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Neurocrine Biosciences, INC. | $114.86 | 2024 | |
| Biodelivery Sciences International, INC. | $109.97 | 2019 | |
| Gilead Sciences, INC. | $97.13 | 2025 | Epclusa |
| Lundbeck LLC | $79.06 | 2024 | Vyepti |
| Biohaven Pharmaceutical Holding Company LTD. | $73.42 | 2022 | |
| Amgen INC. | $72.39 | 2022 | |
| Tersera Therapeutics LLC | $63.28 | 2022-2024 | Prialt |
| Nalu Medical, INC. | $55.04 | 2021-2024 | Nalu Neurostimulation System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $24.06 | 2023 | Qutenza |
| Redhill Biopharma INC. | $14.67 | 2021 | |
| Grt US Holding, INC. | $13.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Conrad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.